Trump Medicare Move May Push More Seniors Into Advantage Plans
A Trump administration decision ending a drug-cost program could spike Part D premiums, steering seniors toward Medicare Advantage.
Here's the trade-off nobody's talking about loudly enough: the Trump administration just cut short a program that was holding Medicare Part D premiums down, and the ripple effects could reshape how millions of seniors get their coverage.
With standalone prescription drug plan costs set to climb, Medicare Advantage — the all-in-one private alternative to traditional Medicare — stands to benefit directly. When Part D gets expensive, the bundled nature of Advantage plans starts looking like a much better deal for cost-conscious retirees.
Read more Congress Members Buying SpaceX Stock Raise Conflict Concerns →
This isn't a small niche shift. Medicare Advantage already covers roughly half of all Medicare enrollees, and any premium shock in Part D could accelerate that migration further. Private insurers running Advantage plans are likely watching this development very closely — it's a potential enrollment tailwind handed to them by federal policy.
For individual seniors, the math is real: if your standalone drug plan premium jumps, you need to run the numbers on whether switching to an Advantage plan makes financial sense during the next open enrollment window. Timing matters. Don't wait until you're sticker-shocked to make the comparison.
The broader policy irony here is hard to miss — a cost-control program gets axed, and the biggest winners may be the private insurers that critics have long argued profit from Medicare privatization. Continue reading at MarketWatch.com
